Liabilities / Assets
80th percentile
Higher debt load relative to assets than 80% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
80th percentile
Higher debt load relative to assets than 80% of similar nonprofits.
Liabilities / Revenue
72nd percentile
Higher debt load relative to revenue than 72% of similar nonprofits.
Net Margin
33rd percentile
Higher net margin than 33% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
9th percentile
Faster asset growth than 9% of similar nonprofits.
Revenue Growth
38th percentile
Faster revenue growth than 38% of similar nonprofits.
Assets
Down$403,773
Down $103,600 (-20%) from 2012
Net Assets
Down$230,211
Down $20,923 (-8.3%) from 2012
Liabilities
Down$173,562
Down $82,677 (-32%) from 2012
Revenue
Down$854,227
Down $4,654 (-0.5%) from 2012
Expenses
Up$875,150
Up $93,670 (+12%) from 2012
Net Income
Down-$20,923
Down $98,324 (-127%) from 2012
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
All activities for research and treatment of Cystic Fibrosis.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
Similar nonprofits based on the same Siviq industry and scale cohort. 2013 filings • 501(c)3 • $500k-$1M nonprofits
Location unavailable
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
6.6% higherLocation unavailable
View Organization501(c)3
Revenue vs current organization
41% lowerAssets vs current organization
112% higherLocation unavailable
View Organization501(c)3
Revenue vs current organization
17% lowerAssets vs current organization
112% higherLocation unavailable
View Organization501(c)3
Revenue vs current organization
About the sameAssets vs current organization
91% lower